Kobayashi Pharmaceutical Co's total assets for Q1 2025 were ¥251.75B, a decrease of -5.13% from the previous quarter. KBYPF total liabilities were ¥44.69B for the fiscal quarter, a -13.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.